Antimalarials (Q72636802)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6165744%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

review article

1 reference

title

Antimalarials (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6165744%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

author name string

F C Koranda

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6165744%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

language of work or name

English

0 references

publication date

1 June 1981

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6165744%20AND%20SRC:MED&resulttype=core&format=json

Journal of the American Academy of Dermatology

28 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6165744%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6165744%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6165744%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

page(s)

650-655

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6165744%20AND%20SRC:MED&resulttype=core&format=json

Treatment of lupus erythematosus with mepacrine

28 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970065-3

7 January 2021

STUDIES ON THE PHARMACOLOGY OF CHLOROQUINE. RECOMMENDATIONS FOR THE TREATMENT OF CHLOROQUINE RETINOPATHY.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970065-3

7 January 2021

Effect of quinacrine (atabrine) upon lupus erythematosus phenomenon

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970065-3

7 January 2021

SUPPRESSION OF IN VITRO LYMPHOCYTE RESPONSES BY CHLOROQUINE.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970065-3

7 January 2021

Chloroquine, quinine, procaine, quinidine, tricyclic antidepressants, and methylxanthines as prostaglandin agonists and antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970065-3

7 January 2021

Inactivation of lysosomal function in normal cultured human fibroblasts by chloroquine

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970065-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970065-3

1 reference

7 January 2021

Effect of Nonsteroid Anti-Inflammatory and Antipyretic Drugs on Prostaglandin Biosynthesis by Human Skin

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970065-3

7 January 2021

The chemosuppression of chemotaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970065-3

7 January 2021

CHLOROQUINE IN BRONCHIAL ASTHMA.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970065-3

7 January 2021

Prevention of Postoperative Deep Venous Thrombosis and Pulmonary Embolism

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970065-3

7 January 2021

Antimalarial Treatment of Rheumatoid Arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970065-3

7 January 2021

Antimalarials in the management of discoid and systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970065-3

7 January 2021

Late sequelae of atabrine dermatitis--a new pre-malignant entity

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970065-3

7 January 2021

Chloroquine seizures. Report of four cases

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970065-3

7 January 2021

TOXIC PSYCHOSIS DUE TO QUINARCRINE AND CHLOROQUINE.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970065-3

7 January 2021

Chloroquine myopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970065-3

7 January 2021

STUDIES ON THE CHRONIC TOXICITY OF CHLOROQUINE (SN-7618)

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970065-3

7 January 2021

Accumulation of chorio-retinotoxic drugs in the foetal eye.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970065-3

7 January 2021

THE OTOTOXICITY OF CHLOROQUINE PHOSPHATE.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970065-3

7 January 2021

Corneal epithelial changes occurring during chloroquine (aralen) therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970065-3

7 January 2021

An appraisal of chloroquine

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970065-3

7 January 2021

EXPERIMENTAL INVESTIGATION OF THE MORPHOGENESIS OF CHLOROQUINE RETINOPATHY.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970065-3

7 January 2021

Chloroquine: ophthalmological safety, and clinical assessment in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970065-3

7 January 2021

Chloroquine retinopathy in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970065-3

7 January 2021

Electroretinography in Patients with Connective Tissue Diseases Treated with Hydroxychloroquine

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970065-3

7 January 2021

Ophthalmological safety of chloroquine

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970065-3

7 January 2021

Ocular lesions in rheumatoid arthritis and related disorders with particular reference to retinopathy. A study of 741 patients treated with and without chloroquine drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970065-3

7 January 2021

The Molecular Basis of the Action of Chloroquine in Porphyria Cutanea Tarda

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970065-3

7 January 2021

Treatment of porphyria cutanea tarda with chloroquine.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970065-3

7 January 2021

Treatment of porphyria cutanea tarda with chloroquine and phlebotomy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970065-3

7 January 2021

10.1016/S0190-9622(81)70065-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6165744%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference